Higher Plant Protein Intake Tied to Lower Risk for Chronic Kidney Disease
THURSDAY, Aug. 10, 2023 -- Greater dietary plant protein intake is associated with a lower risk for incident chronic kidney disease (CKD), according to a study published online July 28 in the American Journal of Kidney Diseases.
Ga Young Heo, M.D.,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 10, 2023 Category: Pharmaceuticals Source Type: news
Chronic Kidney Disease Is Poised To Become The Black Lung of Climate Change
It’s official. July was the world’s hottest month on record, scientists from the European climate monitoring agency confirmed on Aug. 8, a full 1.5°C (2.7°F) warmer than pre-industrial averages, offering a potent taste of what is to come in a world made hotter by climate change. The wildfires and heat waves that wreathed much of the northern hemisphere in smoke this summer? Expect more of the same. The surge in deaths and hospitalization from heat stress and stroke? Ditto. An increase in chronic kidney disease of non-traditional origin? Yup. Wait, what?
[time-brightcove not-tgx=”true”]
O...
Source: TIME: Health - August 9, 2023 Category: Consumer Health News Authors: Aryn Baker Tags: Uncategorized climate change Climate Is Everything healthscienceclimate Source Type: news
The Invisible Cause of Inflammation
A patient came to me with a surprising problem…
This patient was suffering from a lack of energy. He had trouble concentrating during the day. He’d lost his appetite and was in a kind of general malaise.
He’d gone to two other doctors who sent him to a lab for tests…and he brought his lab reports with him.
He had no other symptoms except his blood pressure was a bit high. Right away, the doctor who looked at the report put him on a blood pressure pill.
But he didn’t feel better.
I told him that we were going to stop the medication and test for a suspicion I had. So we measured his heavy metals.
We found t...
Source: Al Sears, MD Natural Remedies - August 9, 2023 Category: Complementary Medicine Authors: Jacob Tags: Health Source Type: news
Albuminuria Testing Falling Short in Patients at Risk for CKD
(MedPage Today) -- Many cases of albuminuria may be missed in the U.S. due to lack of testing among patients at risk for chronic kidney disease (CKD), a cohort study suggested.
Examining electronic health records for nearly 200,000 patients with... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - July 28, 2023 Category: Cardiology Source Type: news
Europe Approves Empagliflozin for Chronic Kidney Disease Europe Approves Empagliflozin for Chronic Kidney Disease
The SGLT2 inhibitor empagliflozin (Jardiance) was approved by European regulators for treating adults with chronic kidney disease. The FDA is reviewing a new drug application for this indication.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - July 27, 2023 Category: Internal Medicine Tags: Diabetes & Endocrinology News Alert Source Type: news
S2 Episode 1: What's Your Approach? MRAs and Chronic Kidney Disease S2 Episode 1: What's Your Approach? MRAs and Chronic Kidney Disease
Join experts Drs Matthew Sparks and James Matthew Luther as they discuss how and why they ' re using mineralocorticoid receptor antagonists to treat patients with diabetic kidney disease in their practice.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 25, 2023 Category: Consumer Health News Tags: Nephrology InDiscussion Source Type: news
Roche enters partnership with Alnylam to co-develop and co-commercialise RNAi therapeutic zilebesiran to treat hypertension in patients with high cardiovascular risk
Partnership combines Roche ’s proven track record of successfully developing and launching innovative medicines worldwide withAlnylam ’s leadership in RNAi therapeuticsZilebesiran, a Phase 2 RNAi therapeutic, has best-in-disease potential for patients with hypertension at high risk of cardiovascular morbidity and mortality, by robustly and durably lowering blood pressureHypertension, the leading cause of cardiovascular disease, affects more than 1.2 billion adults worldwide. While several therapies exist, a significant unmet need, especially for high risk patients, remains.1Basel, 24 July 2023 - Roche (SIX: RO, ROG; OT...
Source: Roche Media News - July 24, 2023 Category: Pharmaceuticals Source Type: news
Roche enters partnership with Alnylam to co-develop and co-commercialise RNAi therapeutic zilebesiran to treat hypertension in patients with high cardiovascular risk
Partnership combines Roche ’s proven track record of successfully developing and launching innovative medicines worldwide withAlnylam ’s leadership in RNAi therapeuticsZilebesiran, a Phase 2 RNAi therapeutic, has best-in-disease potential for patients with hypertension at high risk of cardiovascular morbidity and mortality, by robustly and durably lowering blood pressureHypertension, the leading cause of cardiovascular disease, affects more than 1.2 billion adults worldwide. While several therapies exist, a significant unmet need, especially for high risk patients, remains.1Basel, 24 July 2023 - Roche (SIX: RO, ROG; OT...
Source: Roche Investor Update - July 24, 2023 Category: Pharmaceuticals Source Type: news
Experts Call for Early Screening for Chronic Kidney Disease Experts Call for Early Screening for Chronic Kidney Disease
Nephrologists and family doctors have roles to play in identifying patients with chronic kidney disease, which should be detected earlier, according to experts.Medscape Medical News (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - July 17, 2023 Category: Pathology Tags: Nephrology News Source Type: news
Promise in Chronic Kidney Disease for 3 New Agents Promise in Chronic Kidney Disease for 3 New Agents
Agents from three novel drug classes showed safety and hints of efficacy in patients with varying stages of chronic kidney disease in three phase 2 studies at the European Renal Association Congress.Medscape Medical News (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - July 17, 2023 Category: Transplant Surgery Tags: Nephrology News Source Type: news
Historic redlining linked to worse cardiovascular health for veterans
Patients living in formerly redlined neighborhoods were likelier to be diagnosed with chronic kidney disease, heart failure, diabetes and COPD. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - July 16, 2023 Category: Consumer Health News Authors: Erin Blakemore Source Type: news
Small Link Seen for Acute Kidney Injury, Worsening of Kidney Function in CKD
THURSDAY, July 13, 2023 -- For patients with chronic kidney disease (CKD), the association between mild-to-moderate acute kidney injury (AKI) and worsening subsequent kidney function is small in fully adjusted models, according to a study published... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 13, 2023 Category: Pharmaceuticals Source Type: news
Aurobindo Pharma arm gets USFDA nod for Sevelamer hydrochloride tablets
Aurobindo Pharma Ltd on Wednesday said its wholly-owned subsidiary APL Healthcare has received a final approval from the US health regulator for generic Sevelamer hydrochloride tablets used to control serum phosphorus in patients with chronic kidney disease (CKD) on dialysis. The approval granted by the USFDA to make and market Sevelamer hydrochloride is for tablets of strengths 400 mg and 800 mg, Aurobindo Pharma said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 12, 2023 Category: Pharmaceuticals Source Type: news
AKI Cleared of Worsening CKD Trajectory
(MedPage Today) -- Acute kidney injury (AKI) didn't predict worsening kidney function in people with chronic kidney disease (CKD), a prospective study showed.
According to findings from the Chronic Renal Insufficiency Cohort (CRIC) study, CKD... (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - July 11, 2023 Category: Primary Care Source Type: news
Mild-to-Moderate Kidney Injury Doesn't Worsen CKD Mild-to-Moderate Kidney Injury Doesn't Worsen CKD
Contrary to current conventional wisdom, patients with chronic kidney disease who develop mild or moderate acute kidney injury have only a small subsequent worsening of kidney function.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - July 10, 2023 Category: Cardiology Tags: Nephrology News Source Type: news
